Header Logo

Connection

Alan Landay to HIV Seropositivity

Back to Details
This is a "connection" page, showing publications Alan Landay has written about HIV Seropositivity.
Alan Landay
Connection Strength
1.647
HIV Seropositivity
  1. Chemokines are present in the genital tract of HIV-seropositive and HIV-seronegative women: correlation with other immune mediators. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):454-9.
    View in: PubMed
    Score: 0.160
  2. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS. 1998 Jul 30; 12(11):F123-9.
    View in: PubMed
    Score: 0.160
  3. Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy. DATRI 003 Study Group. Division of AIDS Treatment Research Initiative. AIDS Res Hum Retroviruses. 1998 Mar 20; 14(5):445-51.
    View in: PubMed
    Score: 0.156
  4. Cleavage/alteration of interleukin-8 by matrix metalloproteinase-9 in the female lower genital tract. PLoS One. 2015; 10(1):e0116911.
    View in: PubMed
    Score: 0.125
  5. Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women. J Acquir Immune Defic Syndr. 2014 Nov 01; 67(3):295-303.
    View in: PubMed
    Score: 0.123
  6. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS. 1993 Dec; 7(12):1565-8.
    View in: PubMed
    Score: 0.116
  7. Isolation of HIV-1 from monocytes of individuals negative by conventional culture. J Infect Dis. 1990 Apr; 161(4):706-10.
    View in: PubMed
    Score: 0.090
  8. Monocyte functional studies in asymptomatic, human immunodeficiency disease virus (HIV)-infected individuals. J Clin Immunol. 1988 Nov; 8(6):486-94.
    View in: PubMed
    Score: 0.081
  9. VACUTAINER CPT and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples. BMC Immunol. 2006 May 25; 7:11.
    View in: PubMed
    Score: 0.069
  10. Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals. FEMS Immunol Med Microbiol. 2005 Aug 01; 45(2):129-36.
    View in: PubMed
    Score: 0.063
  11. Anti-CCR5 antibodies in sera of HIV-positive individuals. Hum Immunol. 2001 Feb; 62(2):143-5.
    View in: PubMed
    Score: 0.048
  12. Hormonal levels among HIV-1-seropositive women compared with high-risk HIV-seronegative women during the menstrual cycle. Women's Health Study (WHS) 001 and WHS 001a Study Team. J Womens Health Gend Based Med. 2000 Oct; 9(8):857-63.
    View in: PubMed
    Score: 0.046
  13. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS. 1997 Sep; 11(11):1319-26.
    View in: PubMed
    Score: 0.038
  14. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol. 1997 May; 4(3):358-61.
    View in: PubMed
    Score: 0.037
  15. Transmembrane P-glycoprotein (P-gp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function. AIDS Res Hum Retroviruses. 1995 Aug; 11(8):893-901.
    View in: PubMed
    Score: 0.032
  16. Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. NAID/NICHD Women and Infants Transmission Study Group. Clin Diagn Lab Immunol. 1995 Jul; 2(4):462-8.
    View in: PubMed
    Score: 0.032
  17. Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. Cytometry. 1995 Mar 15; 22(1):10-5.
    View in: PubMed
    Score: 0.032
  18. Glucose transporter 1-expressing proinflammatory monocytes are elevated in combination antiretroviral therapy-treated and untreated HIV+ subjects. J Immunol. 2014 Dec 01; 193(11):5595-603.
    View in: PubMed
    Score: 0.031
  19. Systematic review of the performance of HIV viral load technologies on plasma samples. PLoS One. 2014; 9(2):e85869.
    View in: PubMed
    Score: 0.029
  20. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol. 1993 Oct; 69(1):106-16.
    View in: PubMed
    Score: 0.029
  21. Prediction of CD4 count from CD4 percentage: experience from three laboratories. AIDS. 1993 Jul; 7(7):933-40.
    View in: PubMed
    Score: 0.028
  22. Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women. PLoS One. 2013; 8(4):e61973.
    View in: PubMed
    Score: 0.028
  23. MDSC: a new player in HIV immunopathogenesis. AIDS. 2012 Jul 31; 26(12):1567-9.
    View in: PubMed
    Score: 0.026
  24. Decreased oxidative burst activity of monocytes from asymptomatic HIV-infected individuals. Clin Immunol Immunopathol. 1990 Feb; 54(2):184-91.
    View in: PubMed
    Score: 0.022
  25. Immune responses to abacavir in antigen-presenting cells from hypersensitive patients. AIDS. 2007 Jun 19; 21(10):1233-44.
    View in: PubMed
    Score: 0.018
  26. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. J Immunol. 1999 Aug 01; 163(3):1666-73.
    View in: PubMed
    Score: 0.011
  27. CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients. Eur J Immunol. 1998 Feb; 28(2):646-56.
    View in: PubMed
    Score: 0.010
  28. In vivo decrease in the expression of complement receptor 2 on B-cells in HIV infection. AIDS. 1993 Jan; 7(1):37-41.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.